Pulse nav.journalClub 활발한 토론 트렌드 탐색 질문 연구자

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

개인정보 처리방침

홈 탐색 nav.journalClub 트렌드

⌘+K

August 20, 2008Open Access

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

Key Points

Key points are not available for this paper at this time.

Abstract

Adalimumab therapy seems to be an efficacious option for the treatment of children with juvenile rheumatoid arthritis. (ClinicalTrials.gov number, NCT00048542.)

Read Full Paperexternally

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Lovell et al. (Wed,) studied this question.

synapsesocial.com/papers/69dec9c057c7c8340a5594ca https://doi.org/https://doi.org/10.1056/nejmoa0706290

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis | Synapse

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate2004 · 522 citations
2The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials2001 · 2,553 citations
3Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial2003 · 1,763 citations
4Methotrexate in Resistant Juvenile Rheumatoid Arthritis1992 · 593 citations
5Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.2005 · 123 citations